Product
BCMA CAR-T cells
Aliases
BCMA CAR-T cells injection
4 clinical trials
4 indications
Indication
Multiple MyelomaIndication
TumorIndication
Plasma CellIndication
Multiple Myeloma in RelapseClinical trial
BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple MyelomaStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple MyelomaStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Clinical Study on the Safety and Effectiveness of Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple MyelomaStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Clinical Trial for the Safety and Efficacy of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple MyelomaStatus: Recruiting, Estimated PCD: 2024-04-01